View the Published
Tutivia™ Validation Study
How to Order
Form
Who We Are
Leadership
Careers
Investors
Media
News
Events
Press Releases
Investors
About Verici Dx
Regulatory News
Results, Events, & Presentations
Annual & Interim Reports
Financial Calendar
Shareholder Centre
Corporate Governance
FAQs
AIM Rule 26
Insights
Contact Us
Products
Tutivia™
Clarava™
Protega™
How to Order
Services
Technology
Background
RNA Signatures
Sequencing
Professionals
Clinical Data
Validation Study Results
Importance of a Risk Score
CLIA Lab
Patients
Patient Journey
Partners
AKF
ASN
AST
ASTS
KDIGO
NKF
Educational Center
Patient Journey
Publications
Video Resources
Presentations
Downloadable Documents
Products
Tutivia™
Clarava™
Protega™
How to Order
Services
Technology
Background
RNA Signatures
Sequencing
Professionals
Clinical Data
Validation Study Results
Importance of a Risk Score
CLIA Lab
Patients
Patient Journey
Partners
AKF
ASN
AST
ASTS
KDIGO
NKF
Educational Center
Patient Journey
Publications
Video Resources
Presentations
Downloadable Documents
How to Order
Form
Who We Are
Leadership
Careers
Investors
Media
News
Events
Press Releases
Investors
About Verici Dx
Regulatory News
Results, Events, & Presentations
Annual & Interim Reports
Financial Calendar
Shareholder Centre
Corporate Governance
FAQs
AIM Rule 26
Insights
Contact Us
Presentations
June 19, 2026
Tutivia™ Molecular Risk Scores in Relation to BK Viral Activity, BK Virus Nephropathy, and Rejection Phenotypes in Kidney-Transplant Recipients
ATC 2026 Poster
June 19, 2026
View Poster
June 19, 2026
Evaluation of Tutivia™ Biomarker for Risk of Acute Rejection in Patients Experiencing Delayed Graft Function
ATC 2026 Poster
June 19, 2026
View Poster
June 2, 2024
Performance of Next-Gen Sequencing Biomarker Tutivia™ in Setting of Kidney Delayed Graft Function
ATC 2024 Poster
June 2, 2024
View Poster
close
chevron-down
bars
cross
menu
chevron-down
